In the pharmaceutical, cosmetic, and nutraceutical industries, peptides are highly sought after for their exceptional biological activities. However, traditional chemical synthesis methods, such as Solid-Phase Peptide Synthesis (SPPS), are often held back by high production costs and heavy organic solvent pollution.

In the field of custom peptide synthesis, long-chain peptides (such as those with amino acid sequences exceeding 50 residues) and highly complex modified peptides (featuring configurations like multiple disulfide-bond cyclizations, phosphorylations, fluorescent labeling, or specialized non-natural amino acids) represent the technical high ground of the industry.

During the procurement process for peptide raw materials, many buyers engaging with a supplier for the first time fall into a common misconception: as long as the bench-scale sample they receive achieves a purity of 98% or higher, they assume the facility possesses excellent manufacturing standards and proceed to confidently place a bulk order.